Immunotherapy-induced Addison's disease: A rare, persistent and potentially lethal side-effect

Eur J Cancer. 2018 Jul:97:57-58. doi: 10.1016/j.ejca.2018.04.001. Epub 2018 May 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Addison Disease / chemically induced*
  • Adult
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Fatal Outcome
  • Female
  • Humans
  • Immunotherapy / adverse effects*
  • Uterine Cervical Neoplasms / drug therapy*
  • Uterine Cervical Neoplasms / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab